Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

288.26
BATS BZX Real-Time Price
As of 12:20pm ET
 -0.77 / -0.27%
Today’s Change
223.02
Today|||52-Week Range
338.51
-5.91%
Year-to-Date
UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance
10:52am / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
Jul 28 / Zacks.com - Paid Partner Content
5 Undervalued Growth Stocks to Buy Today
Jul 27 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Jul 28 / Zacks.com - Paid Partner Content
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
Jul 27 / Zacks.com - Paid Partner Content
Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
Jul 28 / Zacks.com - Paid Partner Content
Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure
Jul 27 / TheStreet.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Jul 28 / Zacks.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close289.03
Today’s open287.70
Day’s range286.83 - 289.75
Volume32,845
Average volume (3 months)1,841,379
Market cap$63.3B
Dividend yield--
Data as of 12:20pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio16.9
Price/Sales7.60
Price/Book6.74

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.04-0.08%
GILDGilead Sciences-1.17-1.44%
NBIXNeurocrine Bioscienc...+0.01+0.02%
CTLTCatalent Inc+0.08+0.31%
Data as of 12:21pm ET, 07/29/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$4.68
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs